 Allogeneic Hematopoietic Stem Cell transplantation allo-SCT remains the only curative approach for a number of patients with hematological malignancies. However, the use of allo-SCT can expose patients to prolonged periods of immunosupression during which time viral infections can be a significant cause of morbidity and mortality. 